Cargando…
Response to: Are all non-thymidine analogue backbones appropriate for treating antiretroviral-naïve patients?
Autores principales: | Brothers, C, Cutrell, A, Scott, T, Hernandez, J, Moult, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473177/ https://www.ncbi.nlm.nih.gov/pubmed/16700867 http://dx.doi.org/10.1111/j.1368-5031.2006.00915c.x |
Ejemplares similares
-
Thymidine Analogues for Tracking DNA Synthesis
por: Cavanagh, Brenton L., et al.
Publicado: (2011) -
Use of thymidine analogues to indicate vascular perfusion in tumours
por: Begg, A C, et al.
Publicado: (2000) -
Synthesis and Evaluation
of α-Thymidine
Analogues as Novel Antimalarials
por: Cui, Huaqing, et al.
Publicado: (2012) -
Oligonucleotide analogues with cationic backbone linkages
por: Meng, Melissa, et al.
Publicado: (2018) -
Design of Thymidine Analogues Targeting Thymidilate Kinase of Mycobacterium tuberculosis
por: Owono Owono, Luc Calvin, et al.
Publicado: (2013)